These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 34729704)

  • 1. Impact of Depression Onset and Treatment on the Trend of Annual Medical Costs in Japan: An Exploratory, Descriptive Analysis of Employer-Based Health Insurance Claims Data.
    Cho Y; Mishiro I; Fujimoto S; Nakajima T
    Adv Ther; 2022 Apr; 39(4):1553-1566. PubMed ID: 34729704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diseases prevalent before major depressive disorder diagnosis: an exploratory nested case-control study using health insurance-based claims data.
    Cho Y; Mishiro I; Akaki T; Akimoto T; Fujikawa K
    BMJ Open; 2022 Feb; 12(2):e048233. PubMed ID: 35168961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of hypnotic prescribing for residual insomnia and recurrence of major depressive disorder: a retrospective cohort study using a Japanese health insurance claims database.
    Yamato K; Inada K; Enomoto M; Marumoto T; Takeshima M; Mishima K
    BMC Psychiatry; 2021 Jan; 21(1):40. PubMed ID: 33441086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of direct cost differences among US employees with major depressive disorders using antidepressants.
    Birnbaum HG; Ben-Hamadi R; Greenberg PE; Hsieh M; Tang J; Reygrobellet C
    Pharmacoeconomics; 2009; 27(6):507-17. PubMed ID: 19640013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database.
    Amos TB; Tandon N; Lefebvre P; Pilon D; Kamstra RL; Pivneva I; Greenberg PE
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29474009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of home health and other healthcare delivery pathways among privately insured patients with and without treatment-resistant depression.
    Pilon D; Szukis H; Singer D; Morrison L; Sheehan JJ; Lefebvre P
    Curr Med Res Opin; 2020 May; 36(5):865-874. PubMed ID: 31985319
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Major Depressive Disorder in Japanese Patients with Cancer: A Matched Cohort Study Using Employer-Based Health Insurance Claims Data.
    Akechi T; Fujimoto S; Mishiro I; Murase K
    Clin Drug Investig; 2020 Dec; 40(12):1115-1125. PubMed ID: 33070280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
    Asche CV; Joish VN; Camacho F; Drake CL
    Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of major depressive disorder in Japanese cancer patients: A matched cohort study using employer-based health insurance claims data.
    Akechi T; Mishiro I; Fujimoto S; Murase K
    Psychooncology; 2020 Oct; 29(10):1686-1694. PubMed ID: 32779276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of treatment-resistant depression in privately insured US patients with co-occurring anxiety disorder and/or substance use disorder.
    Zhdanava M; Kuvadia H; Joshi K; Daly E; Pilon D; Rossi C; Morrison L; Lefebvre P; Nelson C
    Curr Med Res Opin; 2021 Jan; 37(1):123-133. PubMed ID: 33124940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insurance.
    Ivanova JI; Birnbaum HG; Chen L; Duhig AM; Dayoub EJ; Kantor ES; Schiller MB; Phillips GA
    Am J Manag Care; 2011 Aug; 17(8):e314-23. PubMed ID: 21851139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Burden of Treatment-Resistant Depression among Adults with Chronic Non-Cancer Pain Conditions and Major Depressive Disorder in the US.
    Shah D; Allen L; Zheng W; Madhavan SS; Wei W; LeMasters TJ; Sambamoorthi U
    Pharmacoeconomics; 2021 Jun; 39(6):639-651. PubMed ID: 33904144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder.
    Seetasith A; Greene M; Hartry A; Burudpakdee C
    J Med Econ; 2018 Sep; 21(9):888-901. PubMed ID: 29862860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descriptive analysis of the economic burden of treatment resistance in a major depressive episode.
    Cai Q; Sheehan JJ; Wu B; Alphs L; Connolly N; Benson C
    Curr Med Res Opin; 2020 Feb; 36(2):329-335. PubMed ID: 31540559
    [No Abstract]   [Full Text] [Related]  

  • 16. An Evaluation of the Clinical and Economic Burden Among Older Adult Medicare-Covered Beneficiaries With Treatment-Resistant Depression.
    Benson C; Szukis H; Sheehan JJ; Alphs L; Yuce H
    Am J Geriatr Psychiatry; 2020 Mar; 28(3):350-362. PubMed ID: 31735488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
    Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
    PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess healthcare resource utilization and healthcare costs among privately and publicly insured patients with major depressive disorder and acute suicidal ideation or behavior in the United States.
    Zhdanava M; Voelker J; Pilon D; Joshi K; Morrison L; Sheehan JJ; Vermette-Laforme M; Lefebvre P; Citrome L
    J Affect Disord; 2022 Aug; 311():303-310. PubMed ID: 35597466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data.
    Touya M; Lawrence DF; Kangethe A; Chrones L; Evangelatos T; Polson M
    BMC Psychiatry; 2022 Mar; 22(1):152. PubMed ID: 35232411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden and antidepressant treatment patterns among patients with major depressive disorder in the United States.
    Zhu L; Ferries E; Suthoff E; Namjoshi M; Bera R
    J Manag Care Spec Pharm; 2022 Nov; 28(11-a Suppl):S2-S13. PubMed ID: 36242598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.